Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. (United States) has no DMF, CEP or site registration linked in our records. 5 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Leadiant Biosciences, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/leadiant-biosciences-inc
Overview
Leadiant Biosciences, Inc. is a pharmaceutical company focused on developing and delivering therapies that address the unmet needs of patients with rare diseases. It operates as a subsidiary of Leadiant Biosciences S.p.A., which is based in Italy.
Therapeutic areas
FDA compliance signals
5 FDA enforcement records linked to this company.
- recall — Class II2023-02-22
Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.
- 4832021-07-08
Interval
- recall — Class III2020-10-21
Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.
- recall — Class III2018-04-25
Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride.
- recall — Class III2018-03-07
Subpotent Drug: Out of specification for an active ingredient cysteamine hydrochloride.
Is this Leadiant Biosciences, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.